Genomic Health to Launch Colon Cancer Test This Quarter | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – Genomic Health will launch its colon cancer test this quarter and will hire additional sales people in connection with the introduction, President and CEO Kim Popovits said Monday at the JP Morgan Healthcare Conference, held here this week.

The pharmacogenomics firm currently has 80 sales people and expects to add another 10 this quarter. Popovits said that its entire sales force would sell both the Oncotype Dx for breast cancer and the new assay for colon cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.